Clinical and pathologic features of familial pancreatic cancer

Cancer

Volumn 120, Issue 23, 2014, Pages 3669-3675

  Humphris, Jeremy L ^a   Johns, Amber L ^a   Simpson, Skye H ^a   Cowley, Mark J ^a   Pajic, Marina ^a,h   Chang, David K ^a,c   Nagrial, Adnan M ^a   Chin, Venessa T ^a   Chantrill, Lorraine A ^a   Pinese, Mark ^a   Mead, R Scott ^a   Gill, Anthony J ^d,e   Samra, Jaswinder S ^e,f   Kench, James G ^a,g   Musgrove, Elizabeth A ^c   Tucker, Katherine M ^b   Spigelman, Allan D ^a,h   Waddell, Nic ⁱ   Grimmond, Sean M ^c,i   Biankin, Andrew V ^a,c  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d CENTRAL SYDNEY AREA HEALTH SERVICE   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f Department of Surgery ^*  (Australia)

^g ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^h UNIVERSITY OF NEW SOUTH WALES   (Australia)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Epidemiology; Hereditary; Pancreatic cancer; Prognosis

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FAMILIAL CANCER; FAMILIAL PANCREAS CANCER; FIRST DEGREE RELATIVE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MELANOMA; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PATIENT CODING; PRECANCER; PREVALENCE; SMOKING; SURVIVAL; TOBACCO; AGED; CARCINOMA; CARCINOMA, PANCREATIC DUCTAL; CASE CONTROL STUDY; DRINKING BEHAVIOR; ENDOMETRIUM TUMOR; EPIDEMIOLOGY; FEMALE; GENETICS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PANCREATIC NEOPLASMS; PATHOLOGY; RISK FACTOR;

AGED; ALCOHOL DRINKING; CARCINOMA; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PANCREATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 84913609307     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.28863     Document Type: Article

References (41)

1. Hidalgo M. Pancreatic cancer. N Engl J Med. 2010; 362:1605-1617.
2. Butturini G, Stocken DD, Wente M.N., et al.; Pancreatic Cancer Meta-Analysis Group. Influence of resection margins and treatment on survival in patients with pancreatic cancer: meta-analysis of randomized controlled trials. Arch Surg. 2008; 143:75-83; discussion 83.
3. Cleary S, Gryfe R, Guindi M., et al. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. J Am Coll Surg. 2004; 198:722-731.
4. Hruban RH, Goggins M, Parsons J., Kern SE. Progression model for pancreatic cancer. Clin Cancer Res. 2000; 6:2969-2972.
5. Iacobuzio-Donahue CA, Velculescu VE, Wolfgang C.L., Hruban RH. Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing. Clin Cancer Res. 2012; 18:4257-4265.
6. Yachida S, Jones S, Bozic I., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature. 2010; 467: 1114-1117.
7. Raimondi S, Maisonneuve P, Lowenfels A. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009; 6:699-708.
8. Bartsch D, Gress T, Langer P. Familial pancreatic cancer-current knowledge. Nat Rev Gastroenterol Hepatol. 2012; 9:445-453.
9. Hruban R, Canto M, Goggins M., Schulick R, Klein A. Update on familial pancreatic cancer. Adv Surg. 2010; 44:293-311.
10. Brand RE, Lerch MM, Rubinstein W.S., et al. Advances in counselling and surveillance of patients at risk for pancreatic cancer. Gut. 2007; 56:1460-1469.
11. Murphy K, Brune K, Griffin C., et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002; 62: 3789-3793.
12. Jones S, Hruban R, Kamiyama M., et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene [serial online]. Science. 2009; 324:217.
13. Roberts N, Jiao Y, Yu J., et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov. 2012; 2:41-46.
14. Lynch H, Fitzsimmons M, Smyrk T., et al. Familial pancreatic cancer: clinicopathologic study of 18 nuclear families. Am J Gastroenterol. 1990; 85:54-60.
15. McFaul C, Greenhalf W, Earl J., et al. Anticipation in familial pancreatic cancer. Gut. 2006; 55:252-258.
16. Gill AJ, Johns AL, Eckstein R, et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology. 2009; 41:161-167.
17. Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC Cancer Staging Manual and the future of TNM. Ann Surg Oncol. 2010; 17:1471-1474.
18. Biankin AV, Waddell N, Kassahn K.S., et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature. 2012; 491:399-405.
19. Ghadirian P, Boyle P, Simard A., Baillargeon J, Maisonneuve P, Perret C. Reported family aggregation of pancreatic cancer within a population-based case-control study in the Francophone community in Montreal, Canada. Int J Pancreatol. 1991; 10(3-4):183-196.
20. Silverman D, Schiffman M, Everhart J., et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999; 80:1830-1837.
21. Del CM, Zerbi A, Falconi M., et al. Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma. Pancreatology. 2007; 7(5-6):459-469.
22. Bartsch D, Kress R, Sina-Frey M, et al. Prevalence of familial pancreatic cancer in Germany. Int J Cancer. 2004; 110:902-906.
23. Hemminki K, Li X. Familial and second primary pancreatic cancers: a nationwide epidemiologic study from Sweden. Int J Cancer. 2003; 103:525-530.
24. Barton J, Schnelldorfer T, Lohse C., et al. Patterns of pancreatic resection differ between patients with familial and sporadic pancreatic cancer. J Gastrointest Surg. 2011; 15:836-842.
25. Schneider R, Slater E, Sina M., et al. German national case collection for familial pancreatic cancer (FaPaCa): ten years experience. Fam Cancer. 2011; 10:323-330.
26. James TA, Sheldon DG, Rajput A, et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004; 101:2722-2726.
27. Rulyak S, Lowenfels A, Maisonneuve P., Brentnall T. Risk factors for the development of pancreatic cancer in familial pancreatic cancer kindreds. Gastroenterology. 2003; 124:1292-1299.
28. Canto M, Harinck F, Hruban R., et al.; International Cancer of the Pancreas Screening (CAPS) Consortium. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer. Gut. 2013; 62:339-347.
29. The Breast Cancer Linkage Consortium. Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst. 1999; 91:1310-1316.
30. Hackert T, Tjaden C, Muller S., et al. Extrapancreatic malignancies in patients with pancreatic cancer: epidemiology and clinical consequences. Pancreas. 2012; 41:212-217.
31. Mariotto AB, Rowland JH, Ries L.A., Scoppa S., Feuer EJ. Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiol Biomarkers Prev. 2007; 16:566-571.
32. Youlden DR, Baade PD. The relative risk of second primary cancers in Queensland, Australia: a retrospective cohort study[serial online]. BMC Cancer. 2011; 11:83.
33. Gerdes B, Ziegler A, Ramaswamy A., Wild A, Langer P, Bartsch D. Multiple primaries in pancreatic cancer patients: indicator of a genetic predisposition? Int J Epidemiol. 2000; 29:999-1003.
34. Lochan R, Daly AK, Reeves H.L., Charnley RM. Family history of cancer and tobacco exposure in index cases of pancreatic ductal ade-nocarcinoma [serial online]. J Oncol. 2011; 2011:215985.
35. Shi C, Klein AP, Goggins M, et al. Increased prevalence of precursor lesions in familial pancreatic cancer patients. Clin Cancer Res. 2009; 15:7737-7743.
36. James T, Sheldon D, Rajput A., et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004; 101:2722-2726.
37. Olson S, Kurtz R. Epidemiology of pancreatic cancer and the role of family history. J Surg Oncol. 2013; 107:1-7.
38. Ben Q, Cai Q, Li Z., et al. The relationship between new-onset diabetes mellitus and pancreatic cancer risk: a case-control study. Eur J Cancer. 2011; 47:248-254.
39. Hwang A, Narayan V, Yang Y. Type 2 diabetes mellitus and survival in pancreatic adenocarcinoma: a retrospective cohort study. Cancer. 2013; 119:404-410.
40. Chu CK, Mazo AE, Goodman M, et al. Preoperative diabetes melli-tus and long-term survival after resection of pancreatic adenocarci-noma. Ann Surg Oncol. 2010; 17:502-513.
41. Love RR, Evans AM, Josten DM. The accuracy of patient reports of a family history of cancer. J Chronic Dis. 1985; 38:289-293.